| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | isonicotinohydroxamic acid | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | -0.0098 | 0.8 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.0096 | 0.8 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.0085 | 0.8 |
| mRNA | SB 216763 | GDSC1000 | pan-cancer | AAC | 0.0095 | 0.8 |
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | 0.0078 | 0.8 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.8 |